Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carl H June

Showing results (121-130 of 460) with videos related to

Pageof 46
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 22, 2017
CAR T-Cell Therapies in Glioblastoma: A First LookDenis Migliorini, Pierre-Yves Dietrich, Roger Stupp, et al.
Annual Review of Immunology|January 16, 2014
Adoptive immunotherapy for cancer or virusesMarcela V Maus, Joseph A Fraietta, Bruce L Levine, et al.
Science Advances|January 11, 2023
Chimeric antigen receptor T cells as adjuvant therapy for unresectable adenocarcinomaUgur Uslu, Tong Da, Charles-Antoine Assenmacher, et al.
Journal of Clinical Pharmacology|November 18, 2020
Chimeric Antigen Receptor T Cell Therapies: A Review of Cellular Kinetic-Pharmacodynamic Modeling ApproachesAnwesha Chaudhury, Xu Zhu, Lulu Chu, et al.
Protein & Cell|May 20, 2017
Novel T cells with improved in vivo anti-tumor activity generated by RNA electroporationXiaojun Liu, Shuguang Jiang, Chongyun Fang, et al.
Cytotherapy|January 21, 2014
Relation of clinical culture method to T-cell memory status and efficacy in xenograft models of adoptive immunotherapyDavid M Barrett, Nathan Singh, Xiaojun Liu, et al.
Cancer Immunology Research|January 11, 2014
Chimeric antigen receptor T Cells with dissociated signaling domains exhibit focused antitumor activity with reduced potential for toxicity in vivoEvripidis Lanitis, Mathilde Poussin, Alex W Klattenhoff, et al.
Cell|August 31, 2021
The immunostimulatory RNA RN7SL1 enables CAR-T cells to enhance autonomous and endogenous immune functionLexus R Johnson, Daniel Y Lee, Jacqueline S Eacret, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 15, 2023
Combined disruption of T cell inflammatory regulators Regnase-1 and Roquin-1 enhances antitumor activity of engineered human T cellsDavid Mai, Omar Johnson, Jordan Reff, et al.
Science Translational Medicine|August 12, 2011
T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemiaMichael Kalos, Bruce L Levine, David L Porter, et al.
Pageof 46

Showing results (121-130 of 460) with videos related to

Sort By:
Pageof 46
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 22, 2017
CAR T-Cell Therapies in Glioblastoma: A First LookDenis Migliorini, Pierre-Yves Dietrich, Roger Stupp, et al.
Annual Review of Immunology|January 16, 2014
Adoptive immunotherapy for cancer or virusesMarcela V Maus, Joseph A Fraietta, Bruce L Levine, et al.
Science Advances|January 11, 2023
Chimeric antigen receptor T cells as adjuvant therapy for unresectable adenocarcinomaUgur Uslu, Tong Da, Charles-Antoine Assenmacher, et al.
Journal of Clinical Pharmacology|November 18, 2020
Chimeric Antigen Receptor T Cell Therapies: A Review of Cellular Kinetic-Pharmacodynamic Modeling ApproachesAnwesha Chaudhury, Xu Zhu, Lulu Chu, et al.
Protein & Cell|May 20, 2017
Novel T cells with improved in vivo anti-tumor activity generated by RNA electroporationXiaojun Liu, Shuguang Jiang, Chongyun Fang, et al.
Cytotherapy|January 21, 2014
Relation of clinical culture method to T-cell memory status and efficacy in xenograft models of adoptive immunotherapyDavid M Barrett, Nathan Singh, Xiaojun Liu, et al.
Cancer Immunology Research|January 11, 2014
Chimeric antigen receptor T Cells with dissociated signaling domains exhibit focused antitumor activity with reduced potential for toxicity in vivoEvripidis Lanitis, Mathilde Poussin, Alex W Klattenhoff, et al.
Cell|August 31, 2021
The immunostimulatory RNA RN7SL1 enables CAR-T cells to enhance autonomous and endogenous immune functionLexus R Johnson, Daniel Y Lee, Jacqueline S Eacret, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 15, 2023
Combined disruption of T cell inflammatory regulators Regnase-1 and Roquin-1 enhances antitumor activity of engineered human T cellsDavid Mai, Omar Johnson, Jordan Reff, et al.
Science Translational Medicine|August 12, 2011
T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemiaMichael Kalos, Bruce L Levine, David L Porter, et al.
Pageof 46